Literature DB >> 9448178

Effects of endoscopic variceal ligation on portal hypertensive gastropathy and gastric mucosal blood flow.

I Yoshikawa1, I Murata, S Nakano, M Otsuki.   

Abstract

OBJECTIVE: Portal hypertensive gastropathy (PHG) has been recognized recently as a potential cause of upper gastrointestinal tract bleeding and is associated with a change in gastric hemodynamic indices in cirrhotic patients with portal hypertension. Endoscopic variceal ligation (EVL) is the treatment of choice for esophageal varices. We investigated the early effect of EVL on PHG and gastric mucosal blood flow (GMBF).
METHODS: We examined 35 cirrhotic patients who were treated by EVL. PHG was evaluated endoscopically and GMBF was measured by laser Doppler flowmetry before and 1 or 2 wk after EVL.
RESULTS: After EVL, only two patients (5.7%) developed severe PHG, 6 (17.1%) developed mild PHG, and 27 (77.1%) showed no change in endoscopic appearance of PHG. In those patients who developed PHG, EVL significantly decreased GMBF at the corpus (p < .05). However, no significant changes of GMBF at the corpus were noted after EVL in those patients who had no worsening of endoscopic features. EVL had no effect on GMBF at the antrum in any patients.
CONCLUSIONS: Endoscopic variceal ligation is safe and does not lead, at least within 1-2 wk, to worsening of gastropathy in most cases. Our finding that gastropathy developed in the presence of reduced GMBF may suggest that PHG develops as a result of congestion caused by blockade of gastric blood drainage rather than by hyperemia.

Entities:  

Mesh:

Year:  1998        PMID: 9448178     DOI: 10.1111/j.1572-0241.1998.071_c.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  8 in total

Review 1.  Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.

Authors:  K W Burak; S S Lee; P L Beck
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

2.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08

3.  Effects of esophageal varice eradication on portal hypertensive gastropathy and fundal varices: a retrospective and comparative study.

Authors:  Osman Yüksel; Seyfettin Köklü; Mehmet Arhan; Omer Faruk Yolcu; Ibrahim Ertuğrul; Bülent Odemiş; Emin Altiparmak; Burhan Sahin
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

Review 4.  Management of gastropathy and gastric vascular ectasia in portal hypertension.

Authors:  Cristina Ripoll; Guadalupe Garcia-Tsao
Journal:  Clin Liver Dis       Date:  2010-05       Impact factor: 6.126

5.  Portal Hypertensive Gastropathy and Gastric Antral Vascular Ectasia.

Authors:  Nelson Garcia; Arun J. Sanyal
Journal:  Curr Treat Options Gastroenterol       Date:  2001-04

6.  Measuring of gastric emptying in Egyptian pediatric patients with portal hypertension by using real-time ultrasound.

Authors:  Mona E Fahmy; Mahmoud A Osman; Rehab A Mahmoud; Lamiaa K Mohamed; Khaled I Seif-elnasr; Ayman E Eskander
Journal:  Saudi J Gastroenterol       Date:  2012 Jan-Feb       Impact factor: 2.485

7.  Helicobacter pylori infection in patients with liver cirrhosis: prevalence and association with portal hypertensive gastropathy.

Authors:  Shanid Abdul Sathar; Sojan George Kunnathuparambil; Srijaya Sreesh; Premaletha Narayanan; Kattoor Ramakrishnan Vinayakumar
Journal:  Ann Gastroenterol       Date:  2014

8.  Quantification of gastric mucosal microcirculation as a surrogate marker of portal hypertension by spatially resolved subdiffuse reflectance spectroscopy in diagnosis of cirrhosis: a proof-of-concept study.

Authors:  Arpan Mohanty; Adam Eshein; Phanisyam Kamineni; Uri Avissar; Charles M Bliss; Michelle T Long; Robert C Lowe; T Carlton Moore; David P Nunes; Vadim Backman; Hemant K Roy
Journal:  Gastrointest Endosc       Date:  2020-12-30       Impact factor: 9.427

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.